A decline in weight and attrition of muscle in colorectal cancer patients receiving chemotherapy with bevacizumab.
A decline in weight and attrition of muscle in colorectal cancer patients receiving chemotherapy with bevacizumab. Med Oncol. 2012 Jun; 29(2):1005-9.